France approves Pfizer–BioNTech vaccine for children aged 5 to 11
The French health authority has authorised the use of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11. The decision follows a review of clinical data and safety assessments.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthFrance approves Pfizer–BioNTech vaccine for children aged 5 to 11
Sign in or subscribeBrowse free archive reportsThe French health authority has authorised the use of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11. The decision follows a review of clinical data and safety assessments.